Recommendation of the President – Lonsurf (trifluridine + tipiracil)
On 31 October 2024, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 117/2024 on the evaluation of the drug Lonsurf (trifluridine + tipiracil) in the drug program “Treatment of patients with colorectal cancer (ICD-10: C18-C20)”
Publication in Public Information Bulletin (BIP) >>